Cargando…

Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro

COVID-19 is undoubtedly the most impactful viral disease of the current century, afflicting millions worldwide. As yet, there is not an approved vaccine, as well as limited options from existing drugs for treating this disease. We hypothesized that combining drugs with independent mechanisms of acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobrowski, Tesia, Chen, Lu, Eastman, Richard T., Itkin, Zina, Shinn, Paul, Chen, Catherine, Guo, Hui, Zheng, Wei, Michael, Sam, Simeonov, Anton, Hall, Matthew D., Zakharov, Alexey V., Muratov, Eugene N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337386/ https://www.ncbi.nlm.nih.gov/pubmed/32637956 http://dx.doi.org/10.1101/2020.06.29.178889

Ejemplares similares

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2021)

Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

Deep learning identifies synergistic drug combinations for treating COVID-19
por: Jin, Wengong, et al.
Publicado: (2021)

Application of temperature-responsive HIS-tag fluorophores to differential scanning fluorimetry screening of small molecule libraries
por: Ronzetti, Michael H., et al.
Publicado: (2022)

Discovery of TMPRSS2 inhibitors from virtual screening
por: Hu, Xin, et al.
Publicado: (2021)

Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
por: Hu, Xin, et al.
Publicado: (2021)

Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
por: Hu, Xin, et al.
Publicado: (2021)

A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model
por: Dorjsuren, Dorjbal, et al.
Publicado: (2022)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2020)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2021)

COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
por: Korn, Daniel, et al.
Publicado: (2020)

COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database
por: Korn, Daniel, et al.
Publicado: (2020)

COVID-19 Knowledge Extractor (COKE): a tool and a web portal to extract drug - target protein associations from the CORD-19 corpus of scientific publications on COVID-19
por: Korn, Daniel, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
por: Shamim, Khalida, et al.
Publicado: (2021)

Learning from history: do not flatten the curve of antiviral research!
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
por: Eastman, Richard T., et al.
Publicado: (2020)

Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19
por: Eastman, Richard T., et al.
Publicado: (2020)

Identifying Small Molecule Compounds that Have Synergistic Effects With Cisplatin and Other Platinum Drugs Using High Throughput Matrix Screening
por: Al-Zubi, Layla, et al.
Publicado: (2022)

High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
por: Mott, Bryan T., et al.
Publicado: (2015)

A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2022)

An OpenData portal to share COVID-19 drug repurposing data in real time
por: Brimacombe, Kyle R., et al.
Publicado: (2020)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity
por: de Menezes, Renata Priscila Barros, et al.
Publicado: (2022)

Computer-Aided Discovery of New Solubility-Enhancing Drug Delivery System
por: Mizera, Mikołaj, et al.
Publicado: (2020)

Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants
por: Jain, Sankalp, et al.
Publicado: (2021)

A critical overview of computational approaches employed for COVID-19 drug discovery
por: Muratov, Eugene N., et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

SYNERGISTIC OR ANTAGONISTIC EFFECT OF DIFFERENT ANTIBODY CONCENTRATIONS ON IN VITRO LYMPHOCYTE CYTOTOXICITY IN THE MOLONEY SARCOMA VIRUS SYSTEM
por: Skurzak, Henryk M., et al.
Publicado: (1972)

An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2020)

Synergistic and Antagonistic Drug Combinations Depend on Network Topology
por: Yin, Ning, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kd5jtip4jukg9chcbd7ar7i7o4